Process Development

Cell Therapy

Optimising and scaling cell therapy manufacturing. Our expertise ensures robust, regulatory-compliant processes for autologous and allogeneic therapies.

Advancing Cell Therapy Manufacturing with Scalable, GMP-Ready Processes

Cell therapy manufacturing presents unique challenges, including process variability, scale-up complexities, and regulatory compliance. Without a structured development approach, companies risk inconsistent product quality, manufacturing inefficiencies, and regulatory hurdles.

We develop scalable, well-controlled cell therapy processes, ensuring they are GMP-compliant and commercially viable. Our expertise spans iPSCs, MSCs, and immune cells, with experience across 2D and 3D culture systems, bioreactor-based expansion, and cryopreservation strategies. We work closely with clients to de-risk scale-up and accelerate technology transfer into GMP manufacturing.

Advance Your Cell Therapy with Expert Process Development

From early-stage optimisation to GMP readiness, we develop scalable, compliance-focused cell therapy processes. Contact us today to discuss how we can accelerate your path to GMP manufacturing.